已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Pharmacoproteomics Identifies PLK1 As Vulnerability for Aggressive B-Cell Lymphomas

PLK1 可药性 癌症研究 基诺美 生物 转录因子 淋巴瘤 细胞生长 癌变 激酶 细胞 细胞周期 癌症 基因 免疫学 细胞生物学 遗传学
作者
Yuan Ren,Chengfeng Bi,Xiaohong Zhao,Tint Lwin,Cheng Wang,Yuan Ji,Ariosto Siqueira Silva,Bijal Shah,Bin Fang,Tao Li,John M. Koomen,Huijuan Jiang,Julio C. Chávez,Lan V. Pham,Praneeth Sudalagunta,Lixin Wan,Xuefeng Wang,William S. Dalton,Lynn C. Moscinski,Kenneth H. Shain
出处
期刊:Blood [Elsevier BV]
卷期号:132 (Supplement 1): 2853-2853 被引量:1
标识
DOI:10.1182/blood-2018-99-118004
摘要

Abstract Background: c-MYC is a transcription factor that promotes oncogenesis by activating and repressing its target genes that control cell growth, metabolism, and proliferation. MYC is deregulated in a large proportion of aggressive B-cell lymphomas. A typical example is the Double-Hit Lymphoma (DHL) and Double-Expression Lymphoma (DEL) which present with a rapidly progressing clinical course, refractory to treatment, poor clinical outcome, and currently considered incurable. Nevertheless, MYC is considered as an "undruggable" target since it has no "active site" amenable to binding by conventional small molecule inhibitors. Moreover, MYC has a broad spectrum of functions in cell proliferation, survival, metabolism, and others, so direct inhibition would likely cause severe side effects. Besides direct inhibition, another practical strategy is to target druggable proteins that are essential for the viability of MYC-driven tumors, inducing MYC-dependent "synthetic lethality". The advantage of such approach is a capability of killing tumor cells discriminately, while leaving non-tumor cells intact or less influenced. This study is designed to identify such targets and explore practical novel strategies to treat MYC-driven lymphomas, especially DHL/DEL. Methods and Results: By integrating activity-based proteomic profiling and drug screens in isogenic MYC on/off lymphoma cells, we identified polo-like kinase-1 (PLK1) as an essential regulator of the MYC-dependent kinome in DHL/DEL. Notably, PLK1 was expressed at high levels in DHL, correlated with MYC expression and connoted poor outcome. Further, PLK1 is directly activated by MYC on transcriptional level and in turn, PLK1 signaling augmented MYC protein stability by promoting its phosphorylation and suppressing its degradation. Thus, MYC and PLK1 form a feed-forward circuit in lymphoma cells. Finally, both in vitro and in vivo studies demonstrated that inhibition of PLK1 triggered degradation of MYC and of the anti-apoptotic protein MCL1, and PLK1 inhibitors showed synergy with BCL-2 antagonists in blocking DHL/DEL cell growth, survival, and tumorigenicity. These data support that PLK1 is a promising therapeutic target in MYC-driven lymphomas. Brief summary: Functional pharmacoproteomics identified PLK1 as a therapeutic vulnerability for MYC-driven lymphoma, which was a synthetic lethal for DHL/DEL when targeted with BCL-2 inhibitors. Disclosures Vose: Roche: Honoraria; Merck Sharp & Dohme Corp.: Research Funding; Acerta Pharma: Research Funding; Seattle Genetics, Inc.: Research Funding; Novartis: Honoraria, Research Funding; Kite Pharma: Research Funding; Bristol Myers Squibb: Research Funding; Epizyme: Honoraria; Legend Pharmaceuticals: Honoraria; Abbvie: Honoraria; Celgene: Research Funding; Incyte Corp.: Research Funding.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
KK完成签到,获得积分10
2秒前
2秒前
coucou完成签到,获得积分10
3秒前
徐向成发布了新的文献求助10
6秒前
大气芒果完成签到,获得积分10
6秒前
7秒前
雨夜完成签到,获得积分10
7秒前
8秒前
zx完成签到,获得积分10
8秒前
lingduyu完成签到,获得积分10
9秒前
9秒前
小蘑菇的应助被常常嘻嘻采纳,获得10
11秒前
11秒前
11秒前
再也不熬夜完成签到,获得积分20
11秒前
Doraemon-2077发布了新的文献求助10
11秒前
123发布了新的文献求助10
12秒前
科研通AI6.3的应助被ddrose采纳,获得10
12秒前
LIUDAN发布了新的文献求助10
13秒前
123456关注了科研通微信公众号
13秒前
活泼冬云发布了新的文献求助10
13秒前
zx发布了新的文献求助10
14秒前
cdercder的应助被飘逸的苡采纳,获得10
14秒前
songsong完成签到,获得积分10
15秒前
15秒前
17秒前
17秒前
饱满的莛发布了新的文献求助10
18秒前
CodeCraft的应助被以123采纳,获得10
18秒前
Cc完成签到 ,获得积分10
19秒前
22秒前
常常嘻嘻发布了新的文献求助10
22秒前
22秒前
李爱国的应助被活泼冬云采纳,获得10
23秒前
ggguang珥完成签到 ,获得积分10
23秒前
24秒前
夕夕完成签到 ,获得积分10
24秒前
CipherSage的应助被虚幻的海白采纳,获得10
25秒前
871004188完成签到,获得积分10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194485
求助须知:如何正确求助?哪些是违规求助? 9580247
关于积分的说明 21870427
捐赠科研通 7794047
什么是DOI,文献DOI怎么找? 3437711
关于科研通互助平台的介绍 2560986
邀请新用户注册赠送积分活动 2484393